Align
Invisalign Itero

Press Release

Apr 24, 2003

Align Technology Reports First Quarter 2003 Financial Results

Align Technology Reports First Quarter 2003 Financial Results

SANTA CLARA, Calif., April 24 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign®, a proprietary method of straightening teeth without wires and brackets, today announced financial results for the quarter ending March 31, 2003. Total revenues for the first quarter of 2003 were $24.7 million, compared to $22.4 million in the fourth quarter of 2002, an increase of 10.3 percent, and $17.1 million in the first quarter of 2002, an increase of 44.3 percent.

"I am pleased with the progress we are making as a company. We are working to create a strong customer base resulting in growth in our case shipments and revenues," said Thomas M. Prescott, President and Chief Executive Officer of Align Technology. "Our expenses have been reduced to levels more consistent with our revenue base, and we believe we have sufficient cash to manage the company beyond profitability. We are building a company focused on customers and we are committed to driving the business performance that will increase shareholder value."

The net loss for the first quarter of 2003 as determined under generally accepted accounting principles ("GAAP") was $8.8 million, or a net loss per share of $0.15. This compares to a net loss for the fourth quarter of 2002 of $13.9 million, or a net loss of $0.27 per share, and a net loss for the first quarter of 2002 of $18.5 million, or a net loss of $0.40 per share. Non-GAAP net loss for the first quarter of 2003, which excludes $4.3 million of stock-based compensation and $0.5 million of restructuring charges, was $4 million, or a non-GAAP net loss of $0.07 per share, compared to non-GAAP net loss of $12.9 million in the first quarter of 2002, which excludes $5.6 million of stock-based compensation, or a non-GAAP net loss of $0.28 per share. The reconciliation of the GAAP to non-GAAP measurements for net loss for the first quarter of 2003 is set forth below within Align Technology's financial statements.

As of March 31, 2003 Align had $37.3 million in cash, cash equivalents and marketable securities, compared to $41.5 million as of December 31, 2002. Align Technology did not incur additional borrowings or draw-downs against its credit facility during the first quarter of 2003.

Align Technology will host a webcast and conference call today, April 24, 2003 at 4:15 p.m. EDT, 1:15 p.m. PDT, to review first quarter 2003 results, as well as discuss future operating trends and guidance on the outlook for the future. To access the webcast, go to "Presentations/Webcasts" in the Investor Relations section of Align Technology's website at http://www.invisalign.com/US/html/corporate/investor_frameset.html . To access the conference call, please dial 415-537-1856 approximately ten minutes prior to the start of the call. If you are unable to listen to the call, an archived web cast will be available beginning approximately one hour after the call's conclusion and will remain available through 5:30 p.m. EDT on April 23, 2004. Additionally, a telephonic replay of the call can be accessed by dialing 800-633-8284 with reservation number 21139506. The replay may be accessed from international locations by dialing 402-977-9140 using the same reservation number. The telephonic replay will be available through 5:30 p.m. EDT on May 8, 2003.

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary new method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor, please visit www.invisalign.com or call 1-800-INVISIBLE.

This news release contains forward-looking statements, including statements regarding Align's current cash position relative to its ability to achieve profitability and its commitment to business performance as a means to increase shareholder value. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement. Factors that might cause such a difference include, but are not limited to, risks relating to Align's history of losses and negative operating cash flows, Align's ability to increase its revenue significantly while controlling expenses, Align's ability to raise additional capital as required, Align's limited operating history, demand for Invisalign, acceptance of Invisalign by consumers and dental professionals, competition from manufacturers of traditional braces, Align's third party manufacturing processes and personnel, foreign operational, political and other risks relating to Align's international manufacturing operations, Align's ability to protect its intellectual property rights, potential intellectual property or product liability claims or litigation, and the potential volatility of the market price of Align's common stock. These and other risks are detailed from time to time in Align's periodic reports filed with the Securities and Exchange Commission, including, but not limited to, its Annual Report on Form 10-K for the fiscal year ended December 31, 2002, which was filed with the Securities and Exchange Commission on March 27, 2003, and its Quarterly Reports on Form 10-Q. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

     Investor Relations Contacts       Press Contacts
     Barbara Domingo                   Shannon Henderson
     Align Technology, Inc.            Fenton Communications
     408-470-1204                      678-417-1767
     bdomingo@aligntech.com            shannon@ethospr.com


     ALIGN TECHNOLOGY, INC.
     CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (A)
     (in thousands, except per share data)
     (unaudited)

                                                  Three Months    Three Months
                                                      Ended           Ended
                                                     March 31,       March 31,
                                                       2003            2002

    Revenues                                         $24,735        $17,141

    Cost of revenues                                  11,810         12,505

    Gross profit                                      12,925          4,636

    Operating expenses:

    Sales and marketing                               10,630         10,327
    General and administrative                         7,894          9,871
    Research and development                           2,985          3,346

    Total operating expenses                          21,509         23,544

    Loss from operations                              (8,584)       (18,908)

    Interest and other income (expense), net            (198)           406

    Net loss                                         ($8,782)      ($18,502)

    Basic and diluted net loss per share              ($0.15)        ($0.40)

    Weighted-average shares used in computing
     basic and diluted net loss per share             57,189         46,152

    (A) Certain reclassifications of prior period amounts have been made to
        conform with current year presentation.


     ALIGN TECHNOLOGY, INC.
     NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (A)
     (in thousands, except per share data)
     (unaudited)

Use of Non-GAAP Financial Information

To supplement our condensed consolidated financial statements presented on a GAAP basis, Align uses a non-GAAP measure of net loss, which is adjusted to exclude certain costs and expenses. We believe that our non-GAAP net loss gives an indication of our baseline performance before other charges that are considered by management to be outside of our core operating results. In addition, our non-GAAP net loss is among the primary indicators management uses as a basis for our planning and forecasting of future periods. The presentation of this additional information should not be considered in isolation or as a substitute for net loss prepared in accordance with generally accepted accounting principles in the United States of America.

                                                  Three Months    Three Months
                                                      Ended           Ended
                                                    March 31,        March 31,
                                                      2003             2002

    Revenues                                         $24,735        $17,141

    Cost of revenues                                  11,089         11,517

    Gross profit (loss)                               13,646          5,624

    Operating expenses:

    Sales and marketing                               10,002          9,516
    General and administrative                         5,202          6,988
    Research and development                           2,252          2,430

    Total operating expenses                          17,456         18,934

    Loss from operations                              (3,810)       (13,310)

    Interest and other income (expense), net            (198)           406

    Net loss                                         ($4,008)      ($12,904)

    Basic and diluted net loss per share              ($0.07)        ($0.28)

    Weighted-average shares used in computing
     basic and diluted net loss per share             57,189         46,152

    (A) Certain reclassifications of prior period amounts have been made to
        conform with current year presentation.

    See Reconciliation of GAAP Net Loss to non-GAAP Net Loss on next page.


     ALIGN TECHNOLOGY, INC.
     RECONCILIATION OF GAAP NET LOSS TO NON-GAAP NET LOSS
     (in thousands, except per share data)
     (unaudited)

                                                  Three Months  Three Months
                                                      Ended        Ended
                                                    March 31,     March 31,
                                                      2003          2002
    Calculation of net loss excluding special items:

    Net loss                                        ($8,782)      ($18,502)

    Items:
    Stock-based compensation expense included in: (A)
    - costs of revenues                                 721            988
    - sales and marketing                               628            811
    - general and administrative                      2,185          2,883
    - research and development                          733            916

    Restructuring costs included in general and
     administrative operating expenses (B)              507             --

    Non-GAAP net loss (excluding special items)     ($4,008)      ($12,904)

    (A)  Stock-based compensation expense represents the amortization of
         deferred stock-based compensation recorded in connection with the
         granting of stock options to employees and non-employees.
         Stock-based compensation expense also includes the accelerated
         vesting of options to several employees in connection with severance
         packages.
    (B)  Restructuring costs represent the remainder of our indirect
         operational activities related to the transition of operations from
         the United Arab Emirates and Pakistan to Costa Rica.


     Align Technology, Inc.
     CONDENSED CONSOLIDATED BALANCE SHEETS
     (in thousands)
     (unaudited)

                                                    March 31,     December 31,
                                                       2003           2002
                        ASSETS
    Current assets:

    Cash and cash equivalents                        $33,997        $35,552
    Restricted cash                                    3,265          3,261
    Marketable securities, short-term                     --          2,693
    Accounts receivable, net                          17,078         16,766
    Inventories, net                                   1,762          1,533
    Deferred costs                                     1,031          1,139
    Other current assets                               6,650          4,888
        Total current assets                          63,783         65,832

    Property and equipment, net                       23,787         25,078
    Other long-term assets                             2,093          1,946

        Total assets                                 $89,663        $92,856

          LIABILITIES AND STOCKHOLDERS' EQUITY

    Current liabilities:

    Accounts payable                                  $2,078         $1,974
    Accrued liabilities                               13,669         12,628
    Deferred revenue                                   2,493          2,130
    Financing debt, current portion                    1,667          1,667
        Total current liabilities                     19,907         18,399

    Financing debt, long-term portion                  2,917          3,333
    Capital lease obligations, net of current portion    425            504

        Total liabilities                             23,249         22,236

    Total stockholders' equity                        66,414         70,620

        Total liabilities and stockholders' equity   $89,663        $92,856


 

Data Provided by Refinitiv. Minimum 15 minutes delayed.